patentstorm.us 258 85 http://www.patentstorm.us/ http://www.patentstorm.us/images/logo.gif PatentStorm -> Applications -> Organic compounds -- part of the class 532-570 series http://www.patentstorm.us/rss/class/applications/rss-552.xml Recent patent applications filings in USPTO Class 552 Organic compounds -- part of the class 532-570 series. Thu, 16 Feb 2012 15:01:26 patents@patentstorm.us en <![CDATA[Use of a Glucocorticoid Composition for the Treatment of Severe and Uncontrolled Asthma]]> http://www.patentstorm.us/applications/20120040945/description.html
  • Application Number:  20120040945
  • Publication Date:  2012-02-16
  • Inventors:  Hofmann, Thomas; Muellinger, Bernard; Scheuch, Gerhard; Kroneberg, Philipp
    • Methods, devices and compositions for treatment of severe and uncontrolled asthma are provided by which high amounts of an inhaled corticosteroid are directed to the small airways of the lower lungs. The invention provides for a substantial decrease in the dose of concurrently administered oral corticosteroids. A particular advantage of the invention is the significant reduction in corticosteroid-related adverse ...
    ]]>     20120040945     <![CDATA[TETRACYCLIC TERPENE SERIES COMPOUNDS, METHODS FOR PREPARING SAME, USES THEREOF AS MEDICINES AND PHARMACEUTICAL COMPOUNDS CONTAINING SAME]]> http://www.patentstorm.us/applications/20120040930/description.html
  • Application Number:  20120040930
  • Publication Date:  2012-02-16
  • Inventors:  Lallemand, Jean-Yves; Khuong-Huu, Françoise; Herlem, Denyse; Molgo, Jordi; Guenard, Daniel; Guillou, Catherine; Sauvaítre, Thibault
    • The invention concerns a triterpene alkaloid of general formula (I). The invention also concerns a method for making same and use thereof as medicine.

    ]]> 20120040930 <![CDATA[METHOD FOR PRODUCING OPTICALLY ACTIVE DIAMINE DERIVATIVE]]> http://www.patentstorm.us/applications/20120035369/description.html

  • Application Number:  20120035369
  • Publication Date:  2012-02-09
  • Inventor:  Kawanami, Koutarou
    • The problem to be solved is to provide an important intermediate for production of an FXa inhibitor. The solution thereto is a method for industrially producing a compound (1) or a compound (4), comprising: [Step 1]: adding a quaternary ammonium salt and a metal azide salt to water to prepare an aqueous solution of an azidification reagent complex comprising quaternary ammonium salt-metal azide salt, and subsequently dehydrating the aqueous solution using an aromatic hydrocarbon solvent to form ...
    ]]>     20120035369     <![CDATA[METHODS FOR FORMING DYED MICROSPHERES AND POPULATIONS OF DYED MICROSPHERES]]> http://www.patentstorm.us/applications/20120035328/description.html
  • Application Number:  20120035328
  • Publication Date:  2012-02-09
  • Inventors:  Hoffacker, Kurt D.; Terpetschnig, Ewald; Lugade, Ananda G.
    • Various methods for forming dyed microspheres are provided. One method includes activating a chemical structure coupled to a dye using heat or light to form a reaction intermediate in the presence of a microsphere. The reaction intermediate covalently attaches to a polymer of the microsphere thereby coupling the dye to the polymer and forming the dyed microsphere. Additional methods are provided for forming a dyed microsphere coupled to a molecule. These methods include dyeing the microspheres ...
    ]]>     20120035328     <![CDATA[BILE ACIDS AND BIGUANIDES AS PROTEASE INHIBITORS FOR PRESERVING THE INTEGRITY OF PEPTIDES IN THE GUT]]> http://www.patentstorm.us/applications/20120035116/description.html
  • Application Number:  20120035116
  • Publication Date:  2012-02-09
  • Inventors:  New, Roger R., C.; Travers, Glen
    • This invention relates to methods of preserving the integrity of peptides in the gut. In particular it concerns the use of certain compounds as inhibitors of gut proteases. Compounds identified as having gut protease inhibitory activity are biguanides, certain bile acids and pharmaceutically acceptable salts of these compounds. This activity makes these compounds useful for co-administration with prophylactic or therapeutic peptides. This invention relates to methods of inhibiting gut proteases ...
    ]]>     20120035116     <![CDATA[LIQUID CRYSTAL DISPLAY DEVICE AND BLUE COLOR FILTER THEREOF]]> http://www.patentstorm.us/applications/20120033164/description.html
  • Application Number:  20120033164
  • Publication Date:  2012-02-09
  • Inventors:  Chen, Chung-Ting; Liao, Chen-Hsien
    • A liquid crystal display device includes a white light emitting diode backlight module for supplying white light, a plurality of red sub-pixels, a plurality of green sub-pixels and a plurality of blue sub-pixels. Each of the blue sub-pixels includes a blue color filter, and each of the blue color filters has a blue light wavelength-transmittance relationship curve. A ratio of a maximum transmittance of the blue light wavelength-transmittance relationship curve to a full width at half maximum ...
    ]]>     20120033164     <![CDATA[AUTO MAGNETIC METAL SALEN COMPLEX COMPOUND]]> http://www.patentstorm.us/applications/20120029167/description.html
  • Application Number:  20120029167
  • Publication Date:  2012-02-02
  • Inventors:  Eguchi, Haruki; ISHIKAWA, Yoshihiro
    • A drug using the magnetic properties of a metal salen complex as represented by the following general formula in order to magnetize the intended drug by chemically binding the drug to a metal salen complex so that the drug can be delivered to the target diseased site. The drug can be delivered to the diseased site using the magnetic properties of the drug per se without using a carrier made of a magnetic substance as in the conventional methods.

    ]]> 20120029167 <![CDATA[DERIVATIVES OF AMINOCYCLOBUTANE OR AMINOCYCLOBUTENE, THEIR METHOD OF PREPARATION AND THEIR USE AS MEDICAL PRODUCTS]]> http://www.patentstorm.us/applications/20120029013/description.html

  • Application Number:  20120029013
  • Publication Date:  2012-02-02
  • Inventors:  Cuisiat, Stéphane; Vacher, Bernard; Newman-Tancredi, Adrian; Vitton, Olivier
    • The present invention concerns compounds of general formula (1), where in:—-a- is a single or double bond, Ar is an aromatic group, substituted or unsubstituted, R1 and R2 each independently or together are: a hydrogen atom or C1-C6 alkyl group, branched or unbranched, saturated or unsaturated, substituted or unsubstituted; the groups R1 and R2 may also form a heterocycle, R3 and R3′ each independently or together are a hydrogen atom or C1-C6 ...
    ]]>     20120029013     <![CDATA[Process for Isolating Tigecycline and Tigecycline Made Therefrom]]> http://www.patentstorm.us/applications/20120028928/description.html
  • Application Number:  20120028928
  • Publication Date:  2012-02-02
  • Inventors:  Mendes, Zita; Villax, Guy
    • The present invention provides a process for isolating tigecycline which process comprises the step of spray drying a solution of tigecycline in a solvent. Preferably the solvent is water or an organic solvent. In another aspect, there is provided tigecycline obtainable by spray drying, particularly in amorphous form. In particular, the invention provides tigecycline obtainable by spray drying according to the process of the ...
    ]]>     20120028928     <![CDATA[Compositions and Methods for Labeling and Imaging Phospholipids]]> http://www.patentstorm.us/applications/20120028290/description.html
  • Application Number:  20120028290
  • Publication Date:  2012-02-02
  • Inventor:  Salic, Adrian
    • The present invention provides a method to label phospholipids in vivo based on the metabolic incorporation of an alkynyl- or azido-labeled metabolic precursor into phospholipids. The resulting phospholipids have alkynyl or azido moieties, which, upon reaction with a labeled azide or alkyne, respectively, form labeled compounds that can be visualized using optical or electron microscopy with high sensitivity and spatial resolution in cells or tissue. The present method provides a valuable tool ...
    ]]>     20120028290     <![CDATA[Polymorphic and Amorphous Salt Forms of Squalamine Dilactate]]> http://www.patentstorm.us/applications/20120022035/description.html
  • Application Number:  20120022035
  • Publication Date:  2012-01-26
  • Inventors:  Chellquist, Eric; Armbruster, Kyle; McLane, Michael; Doubleday, Mary; Gilbert, Charles; Zhang, Xuehai; Levitt, Roy C.
    • The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell ...
    ]]>     20120022035     <![CDATA[CRYSTALLINE FORM C OF TIGECYCLINE DIHYDROCHLORIDE AND METHODS FOR ITS PREPARATION]]> http://www.patentstorm.us/applications/20120022025/description.html
  • Application Number:  20120022025
  • Publication Date:  2012-01-26
  • Inventors:  Wieser, Josef; Pichler, Arthur; Hotter, Andreas; Decristoforo, Martin
    • The present invention relates to crystalline form C of Tigecycline dihydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline form C of Tigecycline dihydrochloride as an intermediate for the preparation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form C of Tigecycline dihydrochloride in an effective amount and to the use of crystalline form C ...
    ]]>     20120022025